PTSM: Pharmaceutical Technology Sourcing and Management, Jun 6, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Jun 6, 2012
Global Feature
Big Pharma's Mid-Year Review
By Patricia Van Arnum
The key activity of the pharmaceutical majors influencing drug development and manufacturing thus far in 2012.
Biotech
An Uneven Path for Biotech Financing
By Patricia Van Arnum
Venture-capital funding is up in 2012, but public financing remains sluggish in the biopharmaceutical industry.
Outsourcing
Channeling Steve Jobs
Service providers must focus on delivering a superior customer experience.
APIs
Seeking Chemocatalytic and Biocatalytic Solutions
By Patricia Van Arnum
Advances in palladium-catalyzed hydrogenation, visible-light photocatalysis, and chemocatalyisis for heterocycles are some recent developments.
Drug Delivery
Technical Insights: Targeted Drug Delivery
By Patricia Van Arnum
Needle-free jet injection systems, gold-coated nanoparticles, and elastic capsules with nanosized flakes advance targeted drug delivery.
CSR and Sustainability Forum
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
Pharma Industry Responds to Global Health Initiatives
By Patricia Van Arnum
The pharmaceutical industry weighs in on WHO global health initiatives, including R&D for diseases of the developing world, a global vaccine action plan, neglected tropical diseases, and counterfeit medicines.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here